| Net Cash Provided by (Used in) Operating Activities |
$1,906,000 |
USD |
-134% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$90,135,000 |
USD |
819309% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$87,310,000 |
USD |
-107690% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
15,356,617 |
shares |
109% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$919,000 |
USD |
-83% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$10,311,000 |
USD |
54% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$936,000 |
USD |
|
Q3 2024 |
Q3 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
$3,209,000 |
USD |
7% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$24,000 |
USD |
-79% |
Q2 2025 |
Q2 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$4,000 |
USD |
-96% |
Q1 2024 |
Q1 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$24,000 |
USD |
-80% |
Q2 2025 |
Q2 2025 |
| Operating Lease, Liability, Current |
$24,000 |
USD |
-74% |
Q2 2025 |
Q2 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$71,000 |
USD |
-24% |
Q4 2024 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
$10,284,000 |
USD |
-7462% |
Q1 2025 |
Q1 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$1,000 |
USD |
-67% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$185,000 |
USD |
-1.6% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$487,000 |
USD |
-16% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$339,900,000 |
USD |
2354% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$3,209,000 |
USD |
7% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$5,757,000 |
USD |
976% |
Q3 2025 |
Q3 2025 |